ESR1 and breast cancer: Similarly, immunohistochemical expression of GATA-3 in human breast cancer showed a direct correlation with that of ER, as the marker was related to the ER− phenotype, which is characteristic of poorly-differentiated aggressive tumors (43, 48, 52).